![](http://raypeat.com/images/rp3.gif)  
---  
  
  
**A R T I C L E**  

  

> **Growth hormone: Hormone of Stress, Aging, & Death?**

> The name "growth hormone" is misleading; stress produces somatic growth, in
> a process called "hormesis." Exercise produces muscle edema, to a degree
> similar to that produced by GH; edema stimulates growth, but GH effect isn't
> limited to bone and muscle.

> Identity of GH: Molecular ambiguity, complex modifications change one
> substance into many; its evolution suggests a role in water regulation.
> Doctrine of a "specific molecule" and "specific receptor" and specific
> effects is a myth.

> The osmoregulatory problem--keeping water under control--is centrally
> involved in stress.

> In mammals, the kidneys and bowel are the main regulators of water balance.

> GH is a stress hormone. Its effects can be produced osmotically, for example
> inducing milk production and cartilage growth, by osmotic (dilution) shock.

> Estrogen produces increased GH, and increases its production in stress.

> Nitric oxide is a pro-aging free radical induced by estrogen, releasing GH;
> all three produce edema.

> Behind edema, hypoxia, hypocarbia; free fatty acids, diabetes, vascular
> leakiness, degenerative kidney changes, connective tissue changes,
> thickened.basement membrane, retinal degeneration. The same changes occur in
> aging: increased permeability; kidney disease, connective tissue changes.

> The absence of GH protects kidneys against degeneration. Osteoarthritis, a
> characteristic aging condition, is caused by estrogen and GH.

> Some studies found that heart failure and bone repair aren't improved by GH;
> GH is very high during heart failure, in which edema contributes to the
> problem; carpal tunnel syndrome, myalgia, tumor growth, gynecomastia, and
> many other problems have been produced by GH treatments.  
>  
> =====================================  
> Bovine Growth Hormone is used to make cows give more milk.  
> Human Growth Hormone is supposed to make men lean and muscular, not to
> increase their milk production.

> =====================================  
>  
> Recently I heard Robert Sapolsky interviewed, and he was describing the
> changes that prepare the body for short-term stress. He said the energy-
> mobilizing hormones, adrenalin and cortisol, increase, while the hormones
> that don't contribute to meeting the immediate problem, including the sex
> hormones and growth hormone, are suppressed, to save energy; growth and
> reproductive processes can be suspended for the few minutes of acute stress,
> to make the body more able to meet its acute needs. He reiterated: Growth
> hormone is suppressed by stress.

> Sapolsky has done very interesting work on the suppression of testosterone
> by stress, and on the way in which brain cells are killed by prolonged
> exposure to glucocorticoids. He showed that if extra glucose is supplied,
> the brain cells can survive their exposure to cortisol. In the body,
> adrenalin and the glucocorticoids increase the availability of glucose.

> In the radio interview, he didn't have time for much detail, but it seemed
> to me that he wasn't talking about the same growth hormone that I have been
> reading about, and trying to understand, for years. Since people have asked
> me to write about the current anti-aging uses of GH, and its use in the
> dairy industry, Sapolsky's statements made me decide to think about some of
> the issues around the hormone.*

>
> ________________________________________________________________________________  
> *If Sapolsky had been talking about just mice and rats, his statement would
> have been generally accurate. Adrenaline stimulates rat pituitary cells to
> secrete GH, and since both increase the amount of free circulating fatty
> acids, it could be that rats' GH is suppressed by a fatty acid excess.

> The "growth hormone" was named long before it was actually found, and the
> substance with that name turns out to be involved in many processes other
> than growth. It is being given to cows to make them produce more milk, and
> it is being given to people with the purpose of making them lean and
> muscular, and with the hope of building stronger bones.  
> It isn't surprising that the Growth Hormone helps breasts develop and
> promotes milk production, since it is very similar to prolactin. GH and
> prolactin are members of a family of proteins that have diverged from each
> other in evolution, but they still have many overlapping effects.

> When GH is treated as a drug, it is supposed to have a discrete identity,
> based on the sequence of its amino acids. But the natural hormone
> (disregarding the existence of a variety of closely related peptides with
> slightly different amino acid composition) varies with time, being
> chemically modified even before it is secreted. For example, its acidic
> amino acids may be methylated, and its lysine groups may combine with sugars
> or carbon dioxide. The history of the protein in the body determines its
> exact structure, and therefore its biological effects.

> Male animals secrete GH in pulses, but females secrete it more steadily.
> This pattern of secretion "masculinizes" or "feminizes" the liver (and other
> organs), determining the pattern of enzyme activity. It would be possible
> (though very difficult) to arrange a system for delivering doses in a
> pulsed, intermittent manner. In cows, this apparently isn't necessary, since
> the purpose of the growth hormone is presumably to "feminize" the milk-
> producing system. But the normal pattern of secretion is much more complex
> than simply being "pulsed" or "continuous," since it, like prolactin
> secretion, is responsive to changes in thyroid, estrogen, diet, stress, and
> many other factors.  
>  
> For example, hormones in this family are, as far back in evolution as they
> have been studied, involved in the regulation of water and minerals. It is
> well established that increased water (hypotonicity) stimulates prolactin,
> and increased sodium inhibits its secretion. Growth hormone is also closely
> involved with the regulation of water and salts.

> One of the best known metabolic effects of GH is that, like adrenalin, it
> mobilizes fatty acids from storage. GH is known to antagonize insulin, and
> one of the ways it does this is simply by the ability of increased free
> fatty acids to block the oxidation of glucose. At puberty, the increased GH
> creates a mild degree of diabetes-like insulin resistance, which tends to
> increase progressively with age.  
>

> In his book, Why Zebras Don't Get Ulcers, Sapolsky acknowledges some
> situations in which GH is increased by stress in humans, but I think he
> misses the real ways in which it operates in stress. One of the interesting
> features of cortisol, which Sapolsky showed killed brain cells by making
> them unable to use glucose efficiently, is that it makes cells take up
> unsaturated fatty acids more easily, interfering with their energy
> production. Since growth hormone also has this kind of "diatebetogenic"
> action, it might be desirable to suppress its secretion during stress, but
> in fact, there are several kinds of stress that clearly increase its
> secretion, and in animals as different as fish, frogs, cows, and people it
> can be seen to play roles in water and salt regulation, growth and
> development, stress, and starvation.  
>

> Heat, hypoglycemia, running, and some types of shock are known to stimulate
> growth hormone secretion, sometimes to levels ten or twenty times higher
> than normal. (Two kinds of stress that usually don't increase GH are cold
> and stimulus-deprivation.) I consider the growth hormone to be, almost as
> much as prolactin, a stress-inducible hormone. That's why I reasoned that,
> if an endocrinologist as good as Sapolsky can misunderstand GH to that
> degree, the public is even more likely to misunderstand the nature of the
> material, and to believe that it somehow acts just on muscle, fat, and
> bones.  
>

> And the normally functioning pituitary appears to be unnecessary to grow to
> normal height. (Kageyama, et al., 1998.)  
>

> W. D. Denckla discovered that the pituitary hormones are in some way able to
> accelerate the process of aging. They block the actions of thyroid hormone,
> decreasing the ability to consume oxygen and produce energy. The diabetes-
> like state that sets in at puberty involves the relative inability to
> metabolize glucose, which is an oxygen-efficient energy source, and a shift
> to fat oxidation, in which more free radicals are produced, and in which
> mitochondrial function is depressed. Diabetics, even though it is supposedly
> an inability of their cells to absorb glucose that defines their disease,
> habitually waste glucose, producing lactic acid even when they aren't
> "stressed" or exerting themselves enough to account for this seemingly
> anaerobic metabolism. It was noticing phenomena of this sort, occurring in a
> great variety of animal species, in different phyla, that led Denckla to
> search for what he called DECO (decreasing consumption of oxygen) or "the
> death hormone." (Vladimir Dilman noticed a similar cluster of events, but he
> consistently interpreted everything in terms of a great genetic program, and
> he offered no solution beyond a mechanistic treatment of the symptoms.)  
>

> Simply increasing the amount of free fatty acids in the blood will act like
> DECO or "the death hormone," but growth hormone has more specific metabolic
> effects than simply increasing our cells' exposure to fatty acids. The
> hormone creates a bias toward oxidizing of the most unsaturated fatty acids
> (Clejan and Schulz), in a process that appears to specifically waste energy.  
> Growth hormone plays an important role in puberty, influencing ovarian
> function, for example.  
>

> Removing animals' pituitaries, Denckla found that their aging was
> drastically slowed. He tried to isolate the death hormone from pituitary
> extracts. He concluded that it wasn't prolactin, although prolactin had some
> of its properties. In the last publication of his that I know of on that
> subject, he reported that he was unable to isolate the death hormone, but
> that it was "in the prolactin fraction." Since rats have at least 14
> different peptides in their prolactin family, not counting the multitude of
> modifications that can occur depending on the exact conditions of secretion,
> it isn't surprising that isolating a single factor with exactly the
> properties of the chronically functioning aging pituitary hasn't been
> successful.  
>

> Denckla's experiments are reminiscent of many others that have identified
> changes in pituitary function as driving forces in aging and degenerative
> diseases.  
>

> Menopause, for example, is the result of overactivity of the pituitary
> gonatropins, resulting from the cumulatively toxic effects of estrogen in
> the hypothalamus.  
>

> A. V. Everitt, in his book on the hypothalamus and pituitary in aging,
> reported on studies in which estrogen caused connective tissues to lose
> their elasticity, and in which progesterone seemed to be an antiestrogenic
> longevity factor. Later, he did a series of experiments that were very
> similar to Denckla's, in which removal of the pituitary slowed the aging
> process. Several of his experiments strongly pointed to the prolactin-growth
> hormone family as the aging factors. Removal of the pituitary caused
> retardation of aging similar to food restriction. These pituitary hormones,
> especially prolactin, are very responsive to food intake, and the growth
> hormone is involved in the connective tissue and kidney changes that occur
> in diabetes and aging.  
>

> A mutant dwarf mouse, called "little," has only 5% to 10% as much growth
> hormone as normal mice, and it has an abnormally long lifespan.  
>

> Many experiments show that prolactin and estrogen have synergistic effects
> in causing tissue degeneration, including cancerization, and that their
> effects tend to operate with fewer protective restraining influences in old
> age. Estrogen stimulates both prolactin and growth hormone secretion. Thirty
> years ago, people were warning that estrogen contraceptives might produce
> diabetes, because they caused chronic elevation of growth hormone and free
> fatty acids.  
> Since estrogen causes a slight tendency to retain water while losing sodium,
> producing hypotonic body fluids, and since hypotonicity is a sufficient
> stimulus to cause prolactin secretion, I have proposed that it is estrogen's
> effect on the body fluids which causes it to stimulate prolactin. In
> pregnancy, the fetus is exposed to fluids more hypotonic than can be
> accounted for by estrogen and prolactin alone; since GH lowers the salt
> concentration of fish when they enter the ocean from freshwater, it seems to
> be a candidate for this effect in pregnancy.  
>

> Growth itself is an intrinsic property of all cells, but the growth hormone
> does have its greatest influence on certain tissues, especially cartilage.
> Gigantism and acromegaly were what originally made people interested in
> looking for a growth hormone, and these are characterized by continued,
> exaggerated enlargement of bones and cartilage. In old age, cartilaginous
> structures such as the bones and ears keep enlarging. The fact that simply
> diluting the culture medium is sufficient to stimulate the growth of
> cartilage suggests that the growth hormone might be acting by its effects on
> water metabolism. In fish which enter fresh water from the ocean, pituitary
> hormones of this family help them to balance salts in this new environment,
> but in the process, they develop osteoporosis and skeletal deformity, of the
> sort that occur more gradually in other animals with aging.  
>

> Growth hormone clearly causes edema, and this is probably involved in the
> pathological processes that it can produce. The expansion of extracellular
> water has been reported, but others have concluded that the increased weight
> of muscles following GH treatment must be the result of "growth," "because
> microscopic examination didn't show edema." Statements of that sort give
> incompetence a bad name, because any student of biology or biochemistry has
> to know, before he does almost any experiment, that the way to determine the
> water content of a tissue is to compare the wet weight to the weight after
> thorough drying. Looking for water under a microscope is the sort of thing
> they do at drug companies to pretend that they have done something.  
>

> Estrogen, growth hormone, and nitric oxide, which tend to work as a system,
> along with free fatty acids, all increase the permeability of blood vessels.
> The leaking of albumin into the urine, which is characteristic of diabetes,
> is promoted by GH. In diabetes and GH treatment, the basement membrane, the
> jelly-like material that forms a foundation for capillary cells, is
> thickened. The reason for this isn't known, but it could be a
> compensatory"anti-leak" response tending to reduce the leakage of proteins
> and fats.  
>

> Besides being involved in kidney degeneration, vascular leakiness
> contributes to brain edema, and probably contributes to the "autoimmune"
> diseases.  
>

> Whatever the exact mechanism may be, it is clearly established that GH
> contributes to kidney degereration, and the lack of GH, even the removal of
> the pituitary, is protective against kidney degeneration.  
>

> Denckla's and Everitt's experiments can be interpreted much more clearly now
> that GH's essential contribution to kidney degeneration is known. Growth
> Hormone may not be precisely the Death Hormone that Denckla was looking for,
> but it is very close to it. Anti-thyroid effects have been seen, and
> possibly even anti-growth effects during gestation, and in kidney disease.
> In newborns, high GH is associated with smaller size and slower growth; in
> one study, this was associated wtith rapid breathing, presumably
> hyperventilation which is associated with stress. The shift to the diabetes-
> like fatty acid oxidation would be expected to inhibit respiration, and the
> chronic elevation of serum free fatty acids will have a generalized
> antithyroid effect. Under the influence of GH, the proportion of unsaturated
> fatty acids is increased, as occurs under the influence of estrogen.  
>

> Growth hormone blocks gonadotropin-stimulated progesterone production, and
> this could also affect thyroid and respiratory metabolism.  
>

> The increase of GH during sleep might seem to be utterly incompatible with
> the idea that it is a stress hormone, but in fact the other stress hormones,
> adrenalin, cortisol, and prolactin also tend to increase during night-time
> sleep. Thyroid function and progesterone function decrease at night. As I
> have argued previously darkness is one of our major stressors. Considering
> GH's tendency to cause edema, tissue swelling, it could play a role in the
> nocturnal increase of the viscosity of blood, as the volume of blood is
> decreased by the leakage of fluid into the tissues. Another process with
> potentially deadly results that increase withaging and stress, is the
> passage of bacteria from the intestine into the blood stream; this process
> is increased under the influence of GH.  
>

> Acute, short term studies definitely show growth hormone to be a stress
> hormone with some destabilizing effects. Over a lifetime, it is possible
> that such things as chronically increased levels of unsaturated fatty acids
> in the blood, and increased leakiness of the blood vessels, could
> cumulatively produce the effects that Denckla ascribed to the Death Hormone.  
>  
> REFERENCES  
>  
> Intern Med 1998 May;37(5):472-5. A hypopituitary patient who attained tall
> stature without growth hormone. Kageyama K, Watanobe H, Nasushita R, Nishie
> M, Horiba N, Suda T. "We describe an unusual patient with hypopituitarism
> who attained tall stature even without growth hormone (GH)."  
> Pediatr. Pulmonol. 1998 26(4):241-9. Sleep, respiratory rate, and growth
> hormone in chronic neonatal lung disease, D. Fitzgerald, et al.  
> "Insulin resistance in puberty [editorial]," Anonymousm Lancet, 1991 May 25,
> 337:8752, 1259-60.  
> "The gonadotropic function of insulin," Poretsky L; Kalin MF, Endocr Rev,
> 1987 May, 8:2, 132-4.1.  
> J Clin Endocrinol Metab 1991 Apr;72(4):768-72 Expansion of extracellular
> volume and suppression of atrial natriuretic peptide after growth hormone
> administration in normal man. Moller J, Jorgensen JO, Moller N, Hansen KW,
> Pedersen EB, Christiansen JS University Department of Endocrinology and
> Internal Medicine, Aarhus Kommunehospital, Denmark. Sodium retention and
> symptoms and signs of fluid retention are commonly recorded during GH
> administration in both GH-deficient patients and normal subjects. Most
> reports have however, been casuistic or uncontrolled. In a randomized double
> blind placebo-controlled cross-over study we therefore examined the effect
> of 14-day GH administration (12 IU sc at 2000 h) on plasma volume,
> extracellular volume (ECV), atrial natriuretic peptide (ANP), arginine
> vasopressin, and the renin angiotensin system in eight healthy adult men. A
> significant GH induced increase in serum insulin growth factor I was
> observed. GH caused a significant increase in ECV (L): 20.45 +/- 0.45 (GH),
> 19.53 +/- 0.48 (placebo) (P less than 0.01), whereas plasma volume (L)
> remained unchanged 3.92 +/- 0.16 (GH), 4.02 +/- 0.13 (placebo). A
> significant decrease in plasma ANP (pmol/L) after GH administration was
> observed: 2.28 +/- 0.54 (GH), 3.16 +/- 0.53 (placebo) P less than 0.01.
> Plasma aldosterone (pmol/L): 129 +/- 14 (GH), 89 +/- 17 (placebo), P = 0.08,
> and plasma angiotensin II (pmol/L) levels: 18 +/- 12 (GH), 14 +/- 7
> (placebo), P = 0.21, were not significantly elevated. No changes in plasma
> arginine vasopressin occurred (1.86 +/- 0.05 pmol/L vs. 1.90 +/- 0.05, P =
> 0.33). Serum sodium and blood pressure remained unaffected. Moderate
> complaints, which could be ascribed to water retention, were recorded in
> four subjects [periorbital edema (n = 3), acral paraesthesia (n = 2) and
> light articular pain (n = 1)]. The symptoms were most pronounced after 2-3
> days of treatment and diminished at the end of the period. In summary, 14
> days of high dose GH administration caused a significant increase in ECV and
> a significant suppression of ANP.  
> Circulation 1991 Jun;83(6):1880-7. Pathogenesis of edema in constrictive
> pericarditis. Studies of body water and sodium, renal function,
> hemodynamics, and plasma hormones before and after pericardiectomy. Anand
> IS, Ferrari R, Kalra GS, Wahi PL, Poole-Wilson PA, Harris PC. "BACKGROUND.
> The pathogenesis of sodium and water accumulation in chronic constrictive
> pericarditis is not well understood and may differ from that in patients
> with chronic congestive heart failure due to myocardial disease. This study
> was undertaken to investigate some of the mechanisms. METHODS AND RESULTS.
> Using standard techniques, the hemodynamics, water and electrolyte spaces,
> renal function, and plasma concentrations of hormones were measured in 16
> patients with untreated constrictive pericarditis and were measured again in
> eight patients after pericardiectomy. The average hemodynamic measurements
> were as follows: cardiac output, 1.98 l/min/m2; right atrial pressure, 22.9
> mm Hg; pulmonary wedge pressure, 24.2 mm Hg; and mean pulmonary artery
> pressure 30.2 mm Hg. The systemic and pulmonary vascular resistances (36.3
> +/- 2.5 and 3.2 +/- 0.3 mm Hg.min.m2/l, respectively) were increased.
> Significant increases occurred in total body water (36%), extracellular
> volume (81%), plasma volume (53%), and exchangeable sodium (63%). The renal
> plasma flow was only moderately decreased (49%), and the glomerular
> filtration rate was normal. Significant increases also occurred in plasma
> concentrations of norepinephrine (3.6 times normal), renin activity (7.2
> time normal), aldosterone (3.4 times normal), cortisol (1.4 times normal),
> growth hormone (21.8 times normal), and atrial natriuretic peptide (5 times
> normal)." "The arterial pressure is maintained more by the expansion of the
> blood volume than by an increase in the peripheral vascular resistance."  
> J Clin Endocrinol Metab 1991 Apr;72(4):768-72 Expansion of extracellular
> volume and suppression of atrial natriuretic peptide after growth hormone
> administration in normal man. Moller J, Jorgensen JO, Moller N, Hansen KW,
> Pedersen EB, Christiansen JS. University Department of Endocrinology and
> Internal Medicine, Aarhus Kommunehospital, Denmark. "Sodium retention and
> symptoms and signs of fluid retention are commonly recorded during GH
> administration in both GH-deficient patients and normal subjects." "GH
> caused a significant increase in ECV (L): 20.45 +/- 0.45 (GH), 19.53 +/-
> 0.48 (placebo) (P less than 0.01), whereas plasma volume (L) remained
> unchanged 3.92 +/- 0.16 (GH), 4.02 +/- 0.13 (placebo)."  
> Edema of cardiac origin. Studies of body water and sodium, renal function,
> hemodynamic indexes, and plasma hormones in untreated congestive cardiac
> failure. Anand IS, Ferrari R, Kalra GS, Wahi PL, Poole-Wilson PA, Harris PC.
> "This study provides data on plasma hormone levels in patients with severe
> clinical congestive cardiac failure who had never received therapy and in
> whom the presence of an accumulation of excess water and sodium had been
> established." "Total body water content was 16% above control, extracellular
> liquid was 33% above control, plasma volume was 34% above control, total
> exchangeable sodium was 37% above control, renal plasma flow was 29% of
> control, and glomerular filtration rate was 65% of control. Plasma
> norepinephrine was consistently increased (on average 6.3 times control),
> whereas adrenaline was unaffected. Although plasma renin activity and
> aldosterone varied widely, they were on average above normal (renin 9.5
> times control, aldosterone 6.4 times control). Plasma atrial natriuretic
> peptide (14.3 times control) and growth hormone (11.5 times control) were
> consistently increased. Cortisol was also increased on average (1.7 times
> control). Vasopressin was increased only in one patient."  
> J Pediatr Endocrinol 1994 Apr-Jun;7(2):93-105. Studies on the renal kinetics
> of growth hormone (GH) and on the GH receptor and related effects in
> animals. Krogsgaard Thomsen M, Friis C, Sehested Hansen B, Johansen P,
> Eschen C, Nowak J, Poulsen K. "Growth hormone (GH) is filtered through the
> kidney, and may exert effects on renal function when presented via the
> circulation. Investigations on kidney-related aspects of GH are increasing
> in number." "Short term administration of GH to rats and humans elicited
> electrolyte and water retention that may cause edema in adults."  
> Mech Ageing Dev 1983 Jul-Aug;22(3-4):233-51 The anti-aging action of
> hypophysectomy in hypothalamic obese rats: effects on collagen aging, age-
> associated proteinuria development and renal histopathology. Everitt AV,
> Wyndham JR, Barnard DL Hypophysectomy in young male Wistar rats aged 70
> days, like food restriction begun at the same age, retarded the life-long
> rate of collagen aging in tail tendon fibres and inhibited the development
> of age-associated proteinuria and renal histopathology. Hypothalamic lesions
> which increased the food intake of hypophysectomized rats from 7 g to 15
> g/day and produced obesity did not alter the rate of either collagen aging
> or proteinuria development, nor reduce life expectancy, but increased the
> incidence of abnormal glomeruli. In the intact rats elevation of food intake
> from 7 g to 15 g/day increased the rate of proteinuria development, but did
> not affect the rate of collagen aging. Hypophysectomy was found to have a
> greater anti-collagen aging effect than food restriction, when food intakes
> were the same in both groups. These studies suggest a pituitary-hormonal
> effect on collagen aging and a food-pituitary-hormone-mediated effect on the
> development of age-associated proteinuria.  
> Growth Dev Aging 1992 Summer;56(2):85-93. Morphometrical analysis of the
> short-term effects of hypophysectomy and food restriction on skeletal muscle
> fibers in relation to growth and aging changes in the rat. Shorey CD,
> Manning LA, Grant AL, Everitt AV.  
> Metabolism of glomerular basement membrane in normal, hypophysectomized, and
> growth-hormone-treated diabetic rats," Reddi AS, Exp Mol Pathol, 1985 Oct,
> 43:2, 196-208. "The in vivo synthesis of the renal glomerular basement
> membrane (GBM) collagen was studied in normal, hypophysectomized (hypox),
> diabetic, and growth-hormone (GH)-treated diabetic rats...." "A significant
> decrease in both proline and hydroxyproline specific activities were
> observed in GBM of hypox rats at all periods of study. Administration of GH
> to hypox rats returned the GBM collagen synthesis to normal. Diabetic GBM
> had higher proline and hydroxyproline specific activities when compared to
> normal rats. Treatment of diabetic rats with GH for 10 days further
> increased both proline and hydroxyproline specific activities when compared
> either to diabetic or normal rats treated with GH. The activity of
> glucosyltransferase, an enzyme involved in the biosynthesis of the
> disaccharide unit of GBM collagen was found to be decreased in glomeruli of
> hypox rats. In contrast, the activity of N-acetyl-beta-glucosaminidase, a
> glycoprotein-degrading enzyme, was found to be significantly increased in
> hypox rats. GH treatment restored both enzyme activities to normal. The
> results of the present study show that GBM collagen synthesis is decreased
> in hypox rats and increased in diabetic rats. ....not only normalized GBM
> collagen synthesis in hypox rats but also caused significant increase in
> diabetic rats. This suggests that the renal GBM metabolism is influenced by
> GH, and this may be of particular significance in view of GH involvement in
> diabetic microvascular complications."  
> Ciba Found Symp 1982;(90):263-78 Prolactin and growth hormone receptors.
> Friesen HG, Shiu RP, Elsholtz H, Simpson S, Hughes J The two hormones
> prolactin and growth hormone exhibit considerable structural homology as
> well as exerting similar biological effects, especially the primate
> hormones. One effect of prolactin that deserves greater attention is its
> action on the immune system including the stimulation of growth of
> experimental lymphomas, both in vivo and in vitro."  
> N Engl J Med 1999 Sep 9;341(11):785-92. Increased mortality associated with
> growth hormone treatment in critically ill adults.

Â© Ray Peat Ph.D. 2013. All Rights Reserved. www.RayPeat.com  
  
  
^^^ Top ^^^  
  

